Polomar Health Services (PMHS) Assets (2022 - 2026)
Polomar Health Services (PMHS) posted Assets of $814726.0 for Q2 2026, up 57.71% on a QoQ basis from $516600.0 in Q1 2026, and down 91.36% year-over-year from $9.4 million in Q2 2025.
Powered by 
Analysis
Polomar Health Services (PMHS) Assets (2022 - 2026) Analysis & Trends
Polomar Health Services has reported Assets for 5 years, with the latest figure at $814726.0 in Q2 2026.
- On a quarterly basis, Assets fell 91.36% year-over-year to $814726.0 in Q2 2026; TTM through Jun 2026 was $814726.0, a 91.36% decrease from a year earlier, with the FY2025 full-year figure at $390043.0, down 96.08% from the prior year.
- Assets was $814726.0 for Q2 2026 at Polomar Health Services, up from $516600.0 in the prior quarter.
- The five-year high for Assets was $10.3 million in Q3 2024, with the low at $244.0 in Q1 2024.
- Average Assets over 5 years is $3.7 million, with a median of $453321.5 recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Assets sank 99.77% in 2024, then soared 4019836.07% in 2025.
- Over 5 years, Assets stood at $261484.0 in 2022, then plunged by 59.04% to $107099.0 in 2023, then surged by 9192.13% to $10.0 million in 2024, then slumped by 96.08% to $390043.0 in 2025, then soared by 108.88% to $814726.0 in 2026.
- The last three Assets figures came in at $814726.0 (Q2 2026), $516600.0 (Q1 2026), and $390043.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 39.86 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 35.04 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.08 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.78 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 24.79 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.59 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.49 Bn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.74 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 75.75 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 814,726.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 814,726.00 |
| Mar 31, 2026 | 516,600.00 |
| Dec 31, 2025 | 390,043.00 |
| Sep 30, 2025 | 9.27 Mn |
| Jun 30, 2025 | 9.43 Mn |
| Mar 31, 2025 | 9.81 Mn |
| Dec 31, 2024 | 9.95 Mn |
| Sep 30, 2024 | 10.30 Mn |
| Jun 30, 2024 | 294.00 |
| Mar 31, 2024 | 244.00 |
| Dec 31, 2023 | 107,099.00 |
| Sep 30, 2023 | 128,966.00 |
| Jun 30, 2023 | 130,224.00 |
| Dec 31, 2022 | 261,484.00 |